Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFATC2
|
ENSG00000101096.15 | nuclear factor of activated T cells 2 |
NFATC3
|
ENSG00000072736.14 | nuclear factor of activated T cells 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFATC2 | hg19_v2_chr20_-_50159198_50159299 | 0.60 | 1.5e-03 | Click! |
NFATC3 | hg19_v2_chr16_+_68119440_68119561 | -0.32 | 1.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_92413353 | 3.44 |
ENST00000556154.1
|
FBLN5
|
fibulin 5 |
chr3_-_141747950 | 3.16 |
ENST00000497579.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr7_+_142919130 | 2.79 |
ENST00000408947.3
|
TAS2R40
|
taste receptor, type 2, member 40 |
chr4_+_41614909 | 2.06 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr1_-_173020056 | 1.97 |
ENST00000239468.2
ENST00000404377.3 |
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18 |
chr12_+_26348582 | 1.96 |
ENST00000535504.1
|
SSPN
|
sarcospan |
chr3_+_152017924 | 1.94 |
ENST00000465907.2
ENST00000492948.1 ENST00000485509.1 ENST00000464596.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr21_-_35899113 | 1.93 |
ENST00000492600.1
ENST00000481448.1 ENST00000381132.2 |
RCAN1
|
regulator of calcineurin 1 |
chr18_+_77155856 | 1.73 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr14_-_92413727 | 1.56 |
ENST00000267620.10
|
FBLN5
|
fibulin 5 |
chr12_-_9268707 | 1.51 |
ENST00000318602.7
|
A2M
|
alpha-2-macroglobulin |
chr7_+_44663908 | 1.51 |
ENST00000543843.1
|
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
chr13_+_97928395 | 1.41 |
ENST00000445661.2
|
MBNL2
|
muscleblind-like splicing regulator 2 |
chr8_+_86121448 | 1.40 |
ENST00000520225.1
|
E2F5
|
E2F transcription factor 5, p130-binding |
chr11_+_128563652 | 1.24 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr6_+_106546808 | 1.22 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr14_+_103589789 | 1.16 |
ENST00000558056.1
ENST00000560869.1 |
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr10_-_116444371 | 1.13 |
ENST00000533213.2
ENST00000369252.4 |
ABLIM1
|
actin binding LIM protein 1 |
chr14_+_32546145 | 1.09 |
ENST00000556611.1
ENST00000539826.2 |
ARHGAP5
|
Rho GTPase activating protein 5 |
chr16_-_66952779 | 1.07 |
ENST00000570262.1
ENST00000394055.3 ENST00000299752.4 |
CDH16
|
cadherin 16, KSP-cadherin |
chr6_+_106534192 | 1.05 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
chr4_+_156587853 | 1.03 |
ENST00000506455.1
ENST00000511108.1 |
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr6_-_10415218 | 0.99 |
ENST00000466073.1
ENST00000498450.1 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr13_-_99667960 | 0.99 |
ENST00000448493.2
|
DOCK9
|
dedicator of cytokinesis 9 |
chr6_-_10415470 | 0.94 |
ENST00000379604.2
ENST00000379613.3 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr8_+_66955648 | 0.94 |
ENST00000522619.1
|
DNAJC5B
|
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
chr16_-_66952742 | 0.92 |
ENST00000565235.2
ENST00000568632.1 ENST00000565796.1 |
CDH16
|
cadherin 16, KSP-cadherin |
chr18_+_77155942 | 0.90 |
ENST00000397790.2
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr13_+_97874574 | 0.89 |
ENST00000343600.4
ENST00000345429.6 ENST00000376673.3 |
MBNL2
|
muscleblind-like splicing regulator 2 |
chr12_-_323689 | 0.88 |
ENST00000428720.1
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
chr8_+_70404996 | 0.86 |
ENST00000402687.4
ENST00000419716.3 |
SULF1
|
sulfatase 1 |
chr11_-_76381029 | 0.79 |
ENST00000407242.2
ENST00000421973.1 |
LRRC32
|
leucine rich repeat containing 32 |
chr7_-_156685841 | 0.78 |
ENST00000354505.4
ENST00000540390.1 |
LMBR1
|
limb development membrane protein 1 |
chr14_+_63671577 | 0.76 |
ENST00000555125.1
|
RHOJ
|
ras homolog family member J |
chr10_+_30722866 | 0.74 |
ENST00000263056.1
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr7_-_22259845 | 0.74 |
ENST00000420196.1
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr4_-_159080806 | 0.73 |
ENST00000590648.1
|
FAM198B
|
family with sequence similarity 198, member B |
chr3_-_112360116 | 0.72 |
ENST00000206423.3
ENST00000439685.2 |
CCDC80
|
coiled-coil domain containing 80 |
chr4_-_16900184 | 0.69 |
ENST00000515064.1
|
LDB2
|
LIM domain binding 2 |
chr5_-_111093759 | 0.66 |
ENST00000509979.1
ENST00000513100.1 ENST00000508161.1 ENST00000455559.2 |
NREP
|
neuronal regeneration related protein |
chr1_-_85870177 | 0.64 |
ENST00000542148.1
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
chr2_+_201997492 | 0.64 |
ENST00000494258.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr9_-_73483958 | 0.62 |
ENST00000377101.1
ENST00000377106.1 ENST00000360823.2 ENST00000377105.1 |
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3 |
chr1_-_246670519 | 0.60 |
ENST00000388985.4
ENST00000490107.1 |
SMYD3
|
SET and MYND domain containing 3 |
chr17_-_36981556 | 0.60 |
ENST00000536127.1
ENST00000225428.5 |
CWC25
|
CWC25 spliceosome-associated protein homolog (S. cerevisiae) |
chr11_+_101983176 | 0.60 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
chr15_-_70994612 | 0.60 |
ENST00000558758.1
ENST00000379983.2 ENST00000560441.1 |
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
chr2_-_191885686 | 0.59 |
ENST00000432058.1
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
chr12_-_50616122 | 0.59 |
ENST00000552823.1
ENST00000552909.1 |
LIMA1
|
LIM domain and actin binding 1 |
chr9_-_13165457 | 0.59 |
ENST00000542239.1
ENST00000538841.1 ENST00000433359.2 |
MPDZ
|
multiple PDZ domain protein |
chr6_+_155537771 | 0.58 |
ENST00000275246.7
|
TIAM2
|
T-cell lymphoma invasion and metastasis 2 |
chr1_-_161207875 | 0.57 |
ENST00000512372.1
ENST00000437437.2 ENST00000442691.2 ENST00000412844.2 ENST00000428574.2 ENST00000505005.1 ENST00000508740.1 ENST00000508387.1 ENST00000504010.1 ENST00000511676.1 ENST00000502985.1 ENST00000367981.3 ENST00000515621.1 ENST00000511944.1 ENST00000511748.1 ENST00000367984.4 ENST00000367985.3 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
chr8_-_81787006 | 0.57 |
ENST00000327835.3
|
ZNF704
|
zinc finger protein 704 |
chr8_-_80680078 | 0.56 |
ENST00000337919.5
ENST00000354724.3 |
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1 |
chr11_+_102188224 | 0.55 |
ENST00000263464.3
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chr17_+_30814707 | 0.55 |
ENST00000584792.1
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
chr8_+_81397876 | 0.55 |
ENST00000430430.1
|
ZBTB10
|
zinc finger and BTB domain containing 10 |
chr1_-_1149506 | 0.54 |
ENST00000379236.3
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4 |
chr3_-_71353892 | 0.54 |
ENST00000484350.1
|
FOXP1
|
forkhead box P1 |
chr12_-_104443890 | 0.54 |
ENST00000547583.1
ENST00000360814.4 ENST00000546851.1 |
GLT8D2
|
glycosyltransferase 8 domain containing 2 |
chr1_-_161207953 | 0.53 |
ENST00000367982.4
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
chr3_+_127770455 | 0.53 |
ENST00000464451.1
|
SEC61A1
|
Sec61 alpha 1 subunit (S. cerevisiae) |
chr1_-_161208013 | 0.53 |
ENST00000515452.1
ENST00000367983.4 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
chr4_-_168155300 | 0.53 |
ENST00000541637.1
|
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr9_+_115913222 | 0.52 |
ENST00000259392.3
|
SLC31A2
|
solute carrier family 31 (copper transporter), member 2 |
chrX_+_9431324 | 0.51 |
ENST00000407597.2
ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X
|
transducin (beta)-like 1X-linked |
chr3_-_149051194 | 0.51 |
ENST00000470080.1
|
TM4SF18
|
transmembrane 4 L six family member 18 |
chr3_+_111578131 | 0.51 |
ENST00000498699.1
|
PHLDB2
|
pleckstrin homology-like domain, family B, member 2 |
chr1_-_161207986 | 0.51 |
ENST00000506209.1
ENST00000367980.2 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
chr15_+_67358163 | 0.49 |
ENST00000327367.4
|
SMAD3
|
SMAD family member 3 |
chrX_+_41193407 | 0.49 |
ENST00000457138.2
ENST00000441189.2 |
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
chr7_+_134551583 | 0.49 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chr13_+_92050928 | 0.49 |
ENST00000377067.3
|
GPC5
|
glypican 5 |
chr8_-_95274536 | 0.47 |
ENST00000297596.2
ENST00000396194.2 |
GEM
|
GTP binding protein overexpressed in skeletal muscle |
chr12_-_50616382 | 0.47 |
ENST00000552783.1
|
LIMA1
|
LIM domain and actin binding 1 |
chr5_-_16742330 | 0.47 |
ENST00000505695.1
ENST00000427430.2 |
MYO10
|
myosin X |
chr15_-_90892669 | 0.46 |
ENST00000412799.2
|
GABARAPL3
|
GABA(A) receptors associated protein like 3, pseudogene |
chrX_+_135730373 | 0.46 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
chr5_+_140772381 | 0.45 |
ENST00000398604.2
|
PCDHGA8
|
protocadherin gamma subfamily A, 8 |
chr1_-_68698197 | 0.45 |
ENST00000370973.2
ENST00000370971.1 |
WLS
|
wntless Wnt ligand secretion mediator |
chrX_+_135730297 | 0.44 |
ENST00000370629.2
|
CD40LG
|
CD40 ligand |
chr4_-_159094194 | 0.44 |
ENST00000592057.1
ENST00000585682.1 ENST00000393807.5 |
FAM198B
|
family with sequence similarity 198, member B |
chr17_+_74372662 | 0.44 |
ENST00000591651.1
ENST00000545180.1 |
SPHK1
|
sphingosine kinase 1 |
chr18_+_55888767 | 0.44 |
ENST00000431212.2
ENST00000586268.1 ENST00000587190.1 |
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr11_+_102188272 | 0.44 |
ENST00000532808.1
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chr8_+_98900132 | 0.44 |
ENST00000520016.1
|
MATN2
|
matrilin 2 |
chr17_+_74261413 | 0.44 |
ENST00000587913.1
|
UBALD2
|
UBA-like domain containing 2 |
chr7_+_28452130 | 0.44 |
ENST00000357727.2
|
CREB5
|
cAMP responsive element binding protein 5 |
chr15_-_37391507 | 0.43 |
ENST00000557796.2
ENST00000397620.2 |
MEIS2
|
Meis homeobox 2 |
chr1_-_55352834 | 0.43 |
ENST00000371269.3
|
DHCR24
|
24-dehydrocholesterol reductase |
chr1_+_61547405 | 0.42 |
ENST00000371189.4
|
NFIA
|
nuclear factor I/A |
chr15_-_50411412 | 0.42 |
ENST00000284509.6
|
ATP8B4
|
ATPase, class I, type 8B, member 4 |
chr10_-_7453445 | 0.42 |
ENST00000379713.3
ENST00000397167.1 ENST00000397160.3 |
SFMBT2
|
Scm-like with four mbt domains 2 |
chr8_+_22423219 | 0.42 |
ENST00000523965.1
ENST00000521554.1 |
SORBS3
|
sorbin and SH3 domain containing 3 |
chr3_+_152017360 | 0.42 |
ENST00000485910.1
ENST00000463374.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr1_+_209602609 | 0.41 |
ENST00000458250.1
|
MIR205HG
|
MIR205 host gene (non-protein coding) |
chr19_+_41509851 | 0.41 |
ENST00000593831.1
ENST00000330446.5 |
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6 |
chr18_-_500692 | 0.41 |
ENST00000400256.3
|
COLEC12
|
collectin sub-family member 12 |
chr1_-_21606013 | 0.41 |
ENST00000357071.4
|
ECE1
|
endothelin converting enzyme 1 |
chr14_+_63671105 | 0.41 |
ENST00000316754.3
|
RHOJ
|
ras homolog family member J |
chr7_+_1126461 | 0.41 |
ENST00000297469.3
|
GPER1
|
G protein-coupled estrogen receptor 1 |
chr9_-_13175823 | 0.41 |
ENST00000545857.1
|
MPDZ
|
multiple PDZ domain protein |
chr3_-_39195037 | 0.41 |
ENST00000273153.5
|
CSRNP1
|
cysteine-serine-rich nuclear protein 1 |
chr6_+_106959718 | 0.41 |
ENST00000369066.3
|
AIM1
|
absent in melanoma 1 |
chr15_+_93443419 | 0.41 |
ENST00000557381.1
ENST00000420239.2 |
CHD2
|
chromodomain helicase DNA binding protein 2 |
chr18_-_53070913 | 0.40 |
ENST00000568186.1
ENST00000564228.1 |
TCF4
|
transcription factor 4 |
chr3_+_148447887 | 0.40 |
ENST00000475347.1
ENST00000474935.1 ENST00000461609.1 |
AGTR1
|
angiotensin II receptor, type 1 |
chr5_+_38846101 | 0.40 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
chr1_-_244006528 | 0.40 |
ENST00000336199.5
ENST00000263826.5 |
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 |
chr17_+_16120512 | 0.40 |
ENST00000581006.1
ENST00000584797.1 ENST00000498772.2 ENST00000225609.5 ENST00000395844.4 ENST00000477745.1 |
PIGL
|
phosphatidylinositol glycan anchor biosynthesis, class L |
chr7_-_150754935 | 0.40 |
ENST00000297518.4
|
CDK5
|
cyclin-dependent kinase 5 |
chr6_+_127439749 | 0.40 |
ENST00000356698.4
|
RSPO3
|
R-spondin 3 |
chr1_+_82266053 | 0.39 |
ENST00000370715.1
ENST00000370713.1 ENST00000319517.6 ENST00000370717.2 ENST00000394879.1 ENST00000271029.4 ENST00000335786.5 |
LPHN2
|
latrophilin 2 |
chr1_+_46640750 | 0.38 |
ENST00000372003.1
|
TSPAN1
|
tetraspanin 1 |
chr15_-_50647274 | 0.38 |
ENST00000543881.1
|
GABPB1
|
GA binding protein transcription factor, beta subunit 1 |
chr5_-_94620239 | 0.37 |
ENST00000515393.1
|
MCTP1
|
multiple C2 domains, transmembrane 1 |
chr1_+_153651078 | 0.37 |
ENST00000368680.3
|
NPR1
|
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
chrX_-_15683147 | 0.37 |
ENST00000380342.3
|
TMEM27
|
transmembrane protein 27 |
chr7_+_1126437 | 0.37 |
ENST00000413368.1
ENST00000397092.1 |
GPER1
|
G protein-coupled estrogen receptor 1 |
chr5_-_115910630 | 0.37 |
ENST00000343348.6
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chrX_+_84498989 | 0.37 |
ENST00000395402.1
|
ZNF711
|
zinc finger protein 711 |
chr12_+_79258547 | 0.36 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr1_-_151319283 | 0.36 |
ENST00000392746.3
|
RFX5
|
regulatory factor X, 5 (influences HLA class II expression) |
chr22_-_43355858 | 0.35 |
ENST00000402229.1
ENST00000407585.1 ENST00000453079.1 |
PACSIN2
|
protein kinase C and casein kinase substrate in neurons 2 |
chr18_-_53089723 | 0.35 |
ENST00000561992.1
ENST00000562512.2 |
TCF4
|
transcription factor 4 |
chr8_-_17555164 | 0.35 |
ENST00000297488.6
|
MTUS1
|
microtubule associated tumor suppressor 1 |
chr4_-_168155417 | 0.35 |
ENST00000511269.1
ENST00000506697.1 ENST00000512042.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr12_+_79258444 | 0.35 |
ENST00000261205.4
|
SYT1
|
synaptotagmin I |
chr5_+_159895275 | 0.35 |
ENST00000517927.1
|
MIR146A
|
microRNA 146a |
chr2_+_27237615 | 0.35 |
ENST00000458529.1
ENST00000402218.1 |
MAPRE3
|
microtubule-associated protein, RP/EB family, member 3 |
chr5_+_140762268 | 0.35 |
ENST00000518325.1
|
PCDHGA7
|
protocadherin gamma subfamily A, 7 |
chr4_+_71200681 | 0.35 |
ENST00000273936.5
|
CABS1
|
calcium-binding protein, spermatid-specific 1 |
chr9_+_124062071 | 0.35 |
ENST00000373818.4
|
GSN
|
gelsolin |
chr4_-_168155169 | 0.34 |
ENST00000534949.1
ENST00000535728.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr5_-_111091948 | 0.34 |
ENST00000447165.2
|
NREP
|
neuronal regeneration related protein |
chr13_+_32838801 | 0.34 |
ENST00000542859.1
|
FRY
|
furry homolog (Drosophila) |
chr4_+_74718906 | 0.34 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
chr20_+_33759854 | 0.34 |
ENST00000216968.4
|
PROCR
|
protein C receptor, endothelial |
chrX_-_63005405 | 0.34 |
ENST00000374878.1
ENST00000437457.2 |
ARHGEF9
|
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
chrX_-_48815633 | 0.34 |
ENST00000428668.2
|
OTUD5
|
OTU domain containing 5 |
chr7_-_82073031 | 0.34 |
ENST00000356253.5
ENST00000423588.1 |
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
chr12_-_71031185 | 0.33 |
ENST00000548122.1
ENST00000551525.1 ENST00000550358.1 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr10_+_128593978 | 0.33 |
ENST00000280333.6
|
DOCK1
|
dedicator of cytokinesis 1 |
chr13_+_46039037 | 0.32 |
ENST00000349995.5
|
COG3
|
component of oligomeric golgi complex 3 |
chr15_-_52587945 | 0.32 |
ENST00000443683.2
ENST00000558479.1 ENST00000261839.7 |
MYO5C
|
myosin VC |
chr10_+_94590910 | 0.32 |
ENST00000371547.4
|
EXOC6
|
exocyst complex component 6 |
chr10_+_120967072 | 0.32 |
ENST00000392870.2
|
GRK5
|
G protein-coupled receptor kinase 5 |
chr5_+_140864649 | 0.32 |
ENST00000306593.1
|
PCDHGC4
|
protocadherin gamma subfamily C, 4 |
chr17_-_7120498 | 0.32 |
ENST00000485100.1
|
DLG4
|
discs, large homolog 4 (Drosophila) |
chr12_+_54393880 | 0.32 |
ENST00000303450.4
|
HOXC9
|
homeobox C9 |
chrX_-_117107680 | 0.32 |
ENST00000447671.2
ENST00000262820.3 |
KLHL13
|
kelch-like family member 13 |
chr1_+_86046433 | 0.32 |
ENST00000451137.2
|
CYR61
|
cysteine-rich, angiogenic inducer, 61 |
chr1_+_244816237 | 0.32 |
ENST00000302550.11
|
DESI2
|
desumoylating isopeptidase 2 |
chr7_+_117120017 | 0.32 |
ENST00000003084.6
ENST00000454343.1 |
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
chr3_-_27764190 | 0.32 |
ENST00000537516.1
|
EOMES
|
eomesodermin |
chr10_+_74451883 | 0.32 |
ENST00000373053.3
ENST00000357157.6 |
MCU
|
mitochondrial calcium uniporter |
chr17_+_36584662 | 0.32 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
chr18_-_53069419 | 0.32 |
ENST00000570177.2
|
TCF4
|
transcription factor 4 |
chr7_-_122342966 | 0.32 |
ENST00000447240.1
|
RNF148
|
ring finger protein 148 |
chr6_-_32191834 | 0.32 |
ENST00000375023.3
|
NOTCH4
|
notch 4 |
chr18_-_52989217 | 0.32 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
chr7_-_122342988 | 0.31 |
ENST00000434824.1
|
RNF148
|
ring finger protein 148 |
chr15_-_37391614 | 0.31 |
ENST00000219869.9
|
MEIS2
|
Meis homeobox 2 |
chr1_-_155959853 | 0.31 |
ENST00000462460.2
ENST00000368316.1 |
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
chr17_+_39261584 | 0.31 |
ENST00000391415.1
|
KRTAP4-9
|
keratin associated protein 4-9 |
chr1_+_84609944 | 0.31 |
ENST00000370685.3
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chrX_-_117107542 | 0.31 |
ENST00000371878.1
|
KLHL13
|
kelch-like family member 13 |
chr17_+_7341586 | 0.30 |
ENST00000575235.1
|
FGF11
|
fibroblast growth factor 11 |
chr9_-_16705069 | 0.30 |
ENST00000471301.2
|
BNC2
|
basonuclin 2 |
chr9_+_103204553 | 0.30 |
ENST00000502978.1
ENST00000334943.6 |
MSANTD3-TMEFF1
TMEFF1
|
MSANTD3-TMEFF1 readthrough transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr15_+_63354769 | 0.30 |
ENST00000558910.1
|
TPM1
|
tropomyosin 1 (alpha) |
chr16_+_55542910 | 0.30 |
ENST00000262134.5
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2 |
chr15_-_50647370 | 0.30 |
ENST00000558970.1
ENST00000396464.3 ENST00000560825.1 |
GABPB1
|
GA binding protein transcription factor, beta subunit 1 |
chr4_-_186733363 | 0.30 |
ENST00000393523.2
ENST00000393528.3 ENST00000449407.2 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr20_+_33464238 | 0.29 |
ENST00000360596.2
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2 |
chr1_-_204135450 | 0.29 |
ENST00000272190.8
ENST00000367195.2 |
REN
|
renin |
chr4_-_168155577 | 0.29 |
ENST00000541354.1
ENST00000509854.1 ENST00000512681.1 ENST00000421836.2 ENST00000510741.1 ENST00000510403.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr1_-_153517473 | 0.29 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
chr1_+_36038971 | 0.29 |
ENST00000373235.3
|
TFAP2E
|
transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon) |
chr6_-_112575838 | 0.29 |
ENST00000455073.1
|
LAMA4
|
laminin, alpha 4 |
chr3_+_130279178 | 0.28 |
ENST00000358511.6
ENST00000453409.2 |
COL6A6
|
collagen, type VI, alpha 6 |
chr19_+_51226648 | 0.28 |
ENST00000599973.1
|
CLEC11A
|
C-type lectin domain family 11, member A |
chr7_+_108210012 | 0.28 |
ENST00000249356.3
|
DNAJB9
|
DnaJ (Hsp40) homolog, subfamily B, member 9 |
chr8_-_117043 | 0.28 |
ENST00000320901.3
|
OR4F21
|
olfactory receptor, family 4, subfamily F, member 21 |
chr9_+_125376948 | 0.28 |
ENST00000297913.2
|
OR1Q1
|
olfactory receptor, family 1, subfamily Q, member 1 |
chr4_+_54966198 | 0.27 |
ENST00000326902.2
ENST00000503800.1 |
GSX2
|
GS homeobox 2 |
chr6_-_62996066 | 0.27 |
ENST00000281156.4
|
KHDRBS2
|
KH domain containing, RNA binding, signal transduction associated 2 |
chr22_-_19512893 | 0.27 |
ENST00000403084.1
ENST00000413119.2 |
CLDN5
|
claudin 5 |
chr1_+_367640 | 0.27 |
ENST00000426406.1
|
OR4F29
|
olfactory receptor, family 4, subfamily F, member 29 |
chr19_+_50380917 | 0.27 |
ENST00000535102.2
|
TBC1D17
|
TBC1 domain family, member 17 |
chr2_+_234580499 | 0.27 |
ENST00000354728.4
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr19_-_1095330 | 0.27 |
ENST00000586746.1
|
POLR2E
|
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa |
chr5_+_173316341 | 0.27 |
ENST00000520867.1
ENST00000334035.5 |
CPEB4
|
cytoplasmic polyadenylation element binding protein 4 |
chr15_-_82338460 | 0.27 |
ENST00000558133.1
ENST00000329713.4 |
MEX3B
|
mex-3 RNA binding family member B |
chr2_+_191334212 | 0.26 |
ENST00000444317.1
ENST00000535751.1 |
MFSD6
|
major facilitator superfamily domain containing 6 |
chr17_+_45331184 | 0.26 |
ENST00000559488.1
ENST00000571680.1 ENST00000435993.2 |
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
chr8_-_23712312 | 0.26 |
ENST00000290271.2
|
STC1
|
stanniocalcin 1 |
chr5_-_176923846 | 0.26 |
ENST00000506537.1
|
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr17_+_7387677 | 0.26 |
ENST00000322644.6
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
chr2_+_234580525 | 0.26 |
ENST00000609637.1
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.0 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.5 | 1.9 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.5 | 2.3 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.4 | 5.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.5 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.3 | 0.8 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.2 | 0.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.2 | 0.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 0.5 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.2 | 0.5 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.2 | 0.5 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.2 | 1.0 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.2 | 0.5 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.2 | 0.8 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.6 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.1 | 0.4 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.1 | 0.6 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.8 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 1.0 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 0.5 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.1 | 0.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.3 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 1.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.4 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.1 | 0.4 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 1.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.3 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.3 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 0.4 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 1.0 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.1 | 0.2 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 0.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.3 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 1.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 2.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 3.9 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.2 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.1 | 0.4 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 3.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.7 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.1 | 0.3 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 1.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.6 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.4 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.2 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.1 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.6 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.4 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.1 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.1 | 0.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.2 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.1 | 0.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.7 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.0 | 0.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.3 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.0 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 0.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.3 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 1.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.0 | 0.2 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.0 | 0.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.2 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.5 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.0 | 0.2 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.0 | 0.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.3 | GO:2000771 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.0 | 0.9 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.0 | 0.1 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.0 | 2.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.1 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.0 | 0.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.4 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 | 0.1 | GO:0060578 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.1 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.0 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.1 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.0 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.0 | 0.1 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.0 | 0.2 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.1 | GO:1903970 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.0 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.0 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.0 | 0.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.0 | GO:2000330 | positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.0 | 0.7 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.0 | 0.1 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.3 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.1 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.0 | 0.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 2.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.0 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.5 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 1.2 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.3 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.0 | 1.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0010269 | response to selenium ion(GO:0010269) |
0.0 | 0.1 | GO:1904044 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) response to aldosterone(GO:1904044) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.1 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.0 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.4 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.3 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 1.0 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.0 | 0.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.0 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.0 | 0.0 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.0 | 0.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0060157 | urea transport(GO:0015840) urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.7 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 1.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.4 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.1 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.4 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 1.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.8 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 1.7 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 1.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.0 | 0.2 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 0.2 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 2.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.0 | 0.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 0.1 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 3.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.5 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 1.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 1.5 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.4 | 2.1 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.3 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 0.9 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.3 | 2.6 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.3 | 0.8 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 0.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.2 | 0.5 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.2 | 0.5 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 0.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 1.8 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 2.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.3 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.6 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 0.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.4 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.1 | 0.4 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.2 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.1 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.0 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.0 | 3.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 1.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.0 | 0.2 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 0.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.2 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.2 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.0 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 5.1 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.0 | 0.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.4 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 1.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 0.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 2.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 1.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 1.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 4.3 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 2.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 1.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 5.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 2.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 1.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 1.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 1.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 1.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.2 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |